Literature DB >> 26392167

[Operative treatment of scoliosis : Preoperative planning, intraoperative monitoring, and postoperative management].

C Wimmer1, A E Siam2, T Pfandlsteiner2.   

Abstract

BACKGROUND: The indication for the surgical treatment of thoracic, lumbar, combined, and thoracolumbar idiopathic and neuropathic scoliosis is a Cobb angle of more than 50° in the thoracic and more than 45° in the lumbar spine. The success of the operation is highly dependent on the pre-operative indication. Standardized medical imaging and close collaboration with anesthetists and pediatricians are necessary in complex cases.
METHODS: We developed a screening routine in which pre-operative diagnosis is performed during hospitalization. The concept is individually developed across disciplines. Surgery for childhood scoliosis always presents a particular challenge for anesthetists and surgeons. Close collaboration during surgery is indispensable for guaranteeing success. Risk factors are determined, evaluated and-if necessary-treated before performing surgery. These factors are also strictly monitored and dealt with during surgery. RESULT: Regular post-operative check-ups are required to ensure early determination and adequate treatment of complications.
CONCLUSION: Operative treatment of scoliosis should only be performed in medical centers that allow for close collaboration and diagnostic investigation.

Entities:  

Keywords:  Anesthesia; Evoked potentials; Intraoperative complications; Neurologic examination; Spine

Mesh:

Year:  2015        PMID: 26392167     DOI: 10.1007/s00132-015-3166-0

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  40 in total

1.  Reversible ischemic myelopathy during scoliosis surgery: a possible role for intravenous lidocaine.

Authors:  W R Klemme; W Burkhalter; D W Polly; L F Dahl; D A Davis
Journal:  J Pediatr Orthop       Date:  1999 Nov-Dec       Impact factor: 2.324

Review 2.  The application of intraoperative monitoring during surgery for spinal deformity.

Authors:  J H Owen
Journal:  Spine (Phila Pa 1976)       Date:  1999-12-15       Impact factor: 3.468

3.  Treatment of idiopathic scoliosis with CD-instrumentation: lumbar pedicle screws versus laminar hooks in 66 patients.

Authors:  C Wimmer; H Gluch; M Nogler; N Walochnik
Journal:  Acta Orthop Scand       Date:  2001-12

4.  Biomechanical testing of three newly developed transpedicular multisegmental fixation systems.

Authors:  S Eggli; F Schläpfer; M Angst; P Witschger; M Aebi
Journal:  Eur Spine J       Date:  1992-09       Impact factor: 3.134

5.  Comparative evaluation of luque and isola instrumentation for treatment of neuromuscular scoliosis.

Authors:  Cornelius Wimmer; Peter Wallnöfer; Nadia Walochnik; Martin Krismer; Vinay Saraph
Journal:  Clin Orthop Relat Res       Date:  2005-10       Impact factor: 4.176

6.  Impact of multimodal intraoperative monitoring during surgery for spine deformity and potential risk factors for neurological monitoring changes.

Authors:  Bin Feng; Guixing Qiu; Jianxiong Shen; Jianguo Zhang; Ye Tian; Shugang Li; Hong Zhao; Yu Zhao
Journal:  J Spinal Disord Tech       Date:  2012-06

7.  Intrathecal morphine for spinal fusion in children.

Authors:  B Dalens; A Tanguy
Journal:  Spine (Phila Pa 1976)       Date:  1988-05       Impact factor: 3.468

8.  Cardiopulmonary dysfunction during minimally invasive thoraco-lumboendoscopic spine surgery.

Authors:  B Vollmar; A Olinger; U Hildebrandt; M D Menger
Journal:  Anesth Analg       Date:  1999-06       Impact factor: 5.108

9.  The relationship between preoperative nutritional status and complications after an operation for scoliosis in patients who have cerebral palsy.

Authors:  D S Jevsevar; L I Karlin
Journal:  J Bone Joint Surg Am       Date:  1993-06       Impact factor: 5.284

10.  [Percutaneous fusion technique on the thoracolumbar spine with the Expedium LIS].

Authors:  Cornelius Wimmer
Journal:  Oper Orthop Traumatol       Date:  2008-12       Impact factor: 1.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.